Literature DB >> 21074904

[Seroepidemiologic study of rubella in childbearing women in Aragon, Spain (2003-2007)].

Rogelio Hernández Díaz1, María Pilar Rodrigo Val, Antonio Misiego Peral, María Lourdes Roc Alfaro, María Begoña Adiego Sancho.   

Abstract

OBJECTIVES: To quantify and identify the rubella-susceptible population in Aragon according to sociodemographic variables, with the aim of assessing compliance with the 5% limit set by the World Health Organization (WHO).
METHODS: Rubella serology tests performed in women of childbearing age in the Miguel Servet Hospital from 2003 to 2007 were studied. A descriptive analysis of seronegativity was performed by age, years of study, and WHO region (for 2007). A logistic regression was performed with the independent variables of age and geographical origin.
RESULTS: We studied 13,136 women. The mean age was 31.2 years. During the study period, 5% were susceptible to rubella (95%CI: 4.63-5.37). In 2003, 8.8% were seronegative and the highest percentage (12.3%) was found in women aged 15 to 19 years. The percentage of seronegativity was higher in foreign-born women (7.7%), especially those from Asia, than in Spanish women (3.3%; p<0.05).
CONCLUSIONS: Postpartum preventive strategies should be established to prevent possible rubella outbreaks and cases of congenital rubella syndrome.
Copyright © 2010 SESPAS. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074904     DOI: 10.1016/j.gaceta.2010.09.003

Source DB:  PubMed          Journal:  Gac Sanit        ISSN: 0213-9111            Impact factor:   2.139


  2 in total

1.  Seroprevalence of antibodies against measles, rubella, mumps, varicella-zoster, and B. Pertussis in young adults of Madrid, Spain.

Authors:  Alba González-Escalada; Laura García-García; Pablo Viguera-Ester; Patricia Marín-García; Jesus García; Angel Gil-de-Miguel; Ruth Gil-Prieto
Journal:  Hum Vaccin Immunother       Date:  2013-06-21       Impact factor: 3.452

Review 2.  Strategies for elimination of rubella in pregnancy and of congenital rubella syndrome in high and upper-middle income countries.

Authors:  E Terracciano; F Amadori; V Pettinicchio; L Zaratti; E Franco
Journal:  J Prev Med Hyg       Date:  2020-04-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.